Helping Patients

Service Through Science

Our purpose is simple: to empower people with the freedom to live healthier and more fulfilling lives, by unlocking new possibilities in life sciences and providing quality healthcare solutions.

Our teams are working passionately to develop novel medicines addressing rare and serious liver diseases.


Primary biliary cholangitis (PBC) is a rare and progressive autoimmune disease that disproportionately affects women over the age of 40.1


Nonalcoholic steatohepatitis (NASH), is a progressive liver disease, which is estimated to affect up to  5% of the US adult population.

REFERENCES: 1. Primary biliary cholangitis (2020) NORD (National Organization for Rare Disorders). Available at: (Accessed: November 29, 2022). 2. Lazarus JZ, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78.